| Dissecting the genomic complexity underlying medulloblastoma DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ... Nature 488 (7409), 100-105, 2012 | 944 | 2012 |
| Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study EC Schwalbe, JC Lindsey, S Nakjang, S Crosier, AJ Smith, D Hicks, ... The Lancet Oncology 18 (7), 958-971, 2017 | 494 | 2017 |
| Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma D Williamson, E Missiaglia, A de Reynies, G Pierron, B Thuille, ... J Clin Oncol 28 (13), 2151-2158, 2010 | 483 | 2010 |
| PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification E Missiaglia, D Williamson, J Chisholm, P Wirapati, G Pierron, F Petel, ... J Clin Oncol 30 (14), 1670-1677, 2012 | 320 | 2012 |
| Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes T Sharma, EC Schwalbe, D Williamson, M Sill, V Hovestadt, M Mynarek, ... Acta neuropathologica 138, 309-326, 2019 | 231 | 2019 |
| Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease RM Hill, S Kuijper, JC Lindsey, K Petrie, EC Schwalbe, K Barker, ... Cancer cell 27 (1), 72-84, 2015 | 209 | 2015 |
| Depletion of RUNX1/ETO in t (8; 21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding A Ptasinska, SA Assi, D Mannari, SR James, D Williamson, J Dunne, ... Leukemia 26 (8), 1829-1841, 2012 | 207 | 2012 |
| Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors J Theruvath, E Sotillo, CW Mount, CM Graef, A Delaidelli, S Heitzeneder, ... Nature medicine 26 (5), 712-719, 2020 | 203 | 2020 |
| DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies EC Schwalbe, D Williamson, JC Lindsey, D Hamilton, SL Ryan, ... Acta neuropathologica 125, 359-371, 2013 | 184 | 2013 |
| Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus B Ho, PD Johann, Y Grabovska, MJ De Dieu Andrianteranagna, F Yao, ... Neuro-oncology 22 (5), 613-624, 2020 | 165 | 2020 |
| Identification of a dynamic core transcriptional network in t (8; 21) AML that regulates differentiation block and self-renewal A Ptasinska, SA Assi, N Martinez-Soria, MR Imperato, J Piper, P Cauchy, ... Cell reports 8 (6), 1974-1988, 2014 | 143 | 2014 |
| Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group NG Gottardo, JR Hansford, JP McGlade, F Alvaro, DM Ashley, S Bailey, ... Acta neuropathologica 127, 189-201, 2014 | 143 | 2014 |
| Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor … E Missiaglia, J Selfe, M Hamdi, D Williamson, G Schaaf, C Fang, J Koster, ... Genes, chromosomes and cancer 48 (6), 455-467, 2009 | 129 | 2009 |
| Relationship Between MYCN Copy Number and Expression in Rhabdomyosarcomas and Correlation With Adverse Prognosis in the Alveolar Subtype D Williamson, YJ Lu, T Gordon, R Sciot, A Kelsey, C Fisher, C Poremba, ... Journal of Clinical Oncology 23 (4), 880-888, 2005 | 127 | 2005 |
| Role for amplification and expression of glypican-5 in rhabdomyosarcoma D Williamson, J Selfe, T Gordon, YJ Lu, K Pritchard-Jones, K Murai, ... Cancer research 67 (1), 57-65, 2007 | 119 | 2007 |
| MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma SL Ryan, EC Schwalbe, M Cole, Y Lu, ME Lusher, H Megahed, K O’Toole, ... Acta neuropathologica 123, 501-513, 2012 | 111 | 2012 |
| Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations K Rehe, K Wilson, S Bomken, D Williamson, J Irving, ML den Boer, ... EMBO molecular medicine 5 (1), 38-51, 2013 | 106 | 2013 |
| Biological and clinical heterogeneity of MYCN-amplified medulloblastoma A Korshunov, M Remke, M Kool, T Hielscher, PA Northcott, D Williamson, ... Acta neuropathologica 123, 515-527, 2012 | 90 | 2012 |
| Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity Y Grabovska, A Mackay, P O’Hare, S Crosier, M Finetti, EC Schwalbe, ... Nature communications 11 (1), 4324, 2020 | 87 | 2020 |
| Comprehensive analysis of chromatin states in atypical teratoid/rhabdoid tumor identifies diverging roles for SWI/SNF and polycomb in gene regulation S Erkek, PD Johann, MA Finetti, Y Drosos, HC Chou, M Zapatka, D Sturm, ... Cancer cell 35 (1), 95-110. e8, 2019 | 75 | 2019 |
Ed SchwalbeNorthumbria UniversityVerified email at northumbria.ac.uk
